Urogen Pharma - 53 Year Dividend History | URGN
Historical dividend payout and yield for Urogen Pharma (URGN) since 1971. The current TTM dividend payout for Urogen Pharma (URGN) as of November 19, 2024 is $0.00. The current dividend yield for Urogen Pharma as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.262B |
$0.083B |
|
UroGen Pharma Ltd. is a clinical stage biopharmaceutical company. It focused on developing urological pathologies with a focus on uro-oncology. The company's product candidates include MitoGel and VesiGel which are in clinical trial stage. Its platform technologies include: RTGel and Immunotherapy. UroGen Pharma Ltd. is based in Ra'anana, Israel.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
